Literature DB >> 18591999

Models of reactive oxygen species in cancer.

Weiqin Lu1, Marcia A Ogasawara, Peng Huang.   

Abstract

Increased generation of reactive oxygen species (ROS) has been observed in cancer, degenerative diseases, and other pathological conditions. ROS can stimulate cell proliferation, promote genetic instability, and induce adaptive responses that enable cancer cells to maintain their malignant phenotypes. However, when cellular redox balance is severely disturbed, high levels of ROS may cause various damages leading to cell death. The studies of ROS effects on biological systems, their underlying mechanisms and therapeutic implications largely depend on proper experimental models. Here we review several in vitro and in vivo models for ROS research.

Entities:  

Year:  2007        PMID: 18591999      PMCID: PMC2390932          DOI: 10.1016/j.ddmod.2007.10.005

Source DB:  PubMed          Journal:  Drug Discov Today Dis Models        ISSN: 1740-6757


  44 in total

1.  The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells.

Authors:  M Sattler; S Verma; G Shrikhande; C H Byrne; Y B Pride; T Winkler; E A Greenfield; R Salgia; J D Griffin
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

2.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

3.  "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally.

Authors:  Isabel García-Cao; Marta García-Cao; Juan Martín-Caballero; Luis M Criado; Peter Klatt; Juana M Flores; Jean-Claude Weill; María A Blasco; Manuel Serrano
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

4.  Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.

Authors:  Ander Matheu; Cristina Pantoja; Alejo Efeyan; Luis M Criado; Juan Martín-Caballero; Juana M Flores; Peter Klatt; Manuel Serrano
Journal:  Genes Dev       Date:  2004-11-01       Impact factor: 11.361

5.  Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts.

Authors:  T T Huang; M Yasunami; E J Carlson; A M Gillespie; A G Reaume; E K Hoffman; P H Chan; R W Scott; C J Epstein
Journal:  Arch Biochem Biophys       Date:  1997-08-15       Impact factor: 4.013

6.  Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis.

Authors:  M B Bogdanov; L E Ramos; Z Xu; M F Beal
Journal:  J Neurochem       Date:  1998-09       Impact factor: 5.372

7.  Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry.

Authors:  Travis W Young; Fang C Mei; Gong Yang; Jennifer A Thompson-Lanza; Jinsong Liu; Xiaodong Cheng
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

8.  A genetically defined model for human ovarian cancer.

Authors:  Jinsong Liu; Gong Yang; Jennifer A Thompson-Lanza; Armand Glassman; Kimberly Hayes; Andrea Patterson; Rebecca T Marquez; Nelly Auersperg; Yinhua Yu; William C Hahn; Gordon B Mills; Robert C Bast
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

9.  Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.

Authors:  C J Kemp; L A Donehower; A Bradley; A Balmain
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

10.  Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.

Authors:  R M Lebovitz; H Zhang; H Vogel; J Cartwright; L Dionne; N Lu; S Huang; M M Matzuk
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  18 in total

1.  The Regulation of Aging and Longevity: A New and Complex Role of p53.

Authors:  Zhaohui Feng; Meihua Lin; Rui Wu
Journal:  Genes Cancer       Date:  2011-04

2.  Evaluating the anticancer properties of liposomal copper in a nude xenograft mouse model of human prostate cancer: formulation, in vitro, in vivo, histology and tissue distribution studies.

Authors:  Yan Wang; San Zeng; Tien-Min Lin; Lisa Krugner-Higby; Doug Lyman; Dana Steffen; May P Xiong
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

3.  SOD2 to SOD1 switch in breast cancer.

Authors:  Luena Papa; Mary Hahn; Ellen L Marsh; Bradley S Evans; Doris Germain
Journal:  J Biol Chem       Date:  2014-01-21       Impact factor: 5.157

4.  Oxidative stress-induced CREB upregulation promotes DNA damage repair prior to neuronal cell death protection.

Authors:  Nicolás Pregi; Laura María Belluscio; Bruno Gabriel Berardino; Daniela Susana Castillo; Eduardo Tomás Cánepa
Journal:  Mol Cell Biochem       Date:  2016-11-05       Impact factor: 3.396

Review 5.  Targeting cancer cell mitochondria as a therapeutic approach.

Authors:  Shijun Wen; Daqian Zhu; Peng Huang
Journal:  Future Med Chem       Date:  2013-01       Impact factor: 3.808

6.  Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro.

Authors:  Łukasz Bułdak; Krzysztof Łabuzek; Rafał Jakub Bułdak; Grzegorz Machnik; Aleksandra Bołdys; Marcin Basiak; Okopień Bogusław
Journal:  Exp Ther Med       Date:  2016-01-11       Impact factor: 2.447

Review 7.  Role of oxidatively induced DNA lesions in human pathogenesis.

Authors:  Olga A Sedelnikova; Christophe E Redon; Jennifer S Dickey; Asako J Nakamura; Alexandros G Georgakilas; William M Bonner
Journal:  Mutat Res       Date:  2010-01-08       Impact factor: 2.433

Review 8.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Authors:  Dunyaporn Trachootham; Jerome Alexandre; Peng Huang
Journal:  Nat Rev Drug Discov       Date:  2009-05-29       Impact factor: 84.694

9.  Expression of TOMM34 and Its Clinicopathological Correlations in Urothelial Carcinoma of the Bladder.

Authors:  Mohamed A H Ahmed; Mohamed Hassan Ali; Hashem Hafez Abbas; Gamal Ali Elatrash; Abd AlRahman Mohammad Foda
Journal:  Pathol Oncol Res       Date:  2018-10-31       Impact factor: 3.201

10.  Evaluation of the in vivo antihypertensive effect and antioxidant activity of HL-7 and HL-10 peptide in mice.

Authors:  Zahra Setayesh-Mehr; Leila Vafadar Ghasemi; Ahmad Asoodeh
Journal:  Mol Biol Rep       Date:  2021-07-21       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.